JDRF is investing in a major initiative to speed the development of an artificial pancreas - a system that could revolutionise the treatment of type 1 diabetes.
JDRF is leading the journey towards the artificial pancreas, investing $94 million so far towards making the technology a reality for people living with type 1. Learn more about how 2014 has proven to be a year of remarkable progress.
An artificial pancreas is a system comprising an insulin pump, a continuous glucose monitor and an algorithm. Learn more about the artificial pancreas and how it works.
JDRF exists to cure, treat and prevent type 1 diabetes and its complications. An artificial pancreas system could help many people with type 1 diabetes keep better control of their blood glucose levels, thereby reducing their risk of long-term complications and protecting them against hypoglycaemia. Read more about why this is important.
JDRF’s goal is to accelerate the development, regulatory approval and clinician adoption of effective artificial pancreas technologies. Read more about how we hope to do this with our Artificial Pancreas Project.
The artificial pancreas is a global project. We have research teams based all over the world collaborating with one another to draw in different expertise. Find out more about where the research is happening.
The University of Cambridge team, led by Dr Roman Hovorka, is one of the core research groups that form part of the JDRF Artificial Pancreas Consortium. Read the latest on what his team is working on.
We would not be able to continue funding research projects like this without your generous support. Find out how you can help the artificial pancreas become a reality.